Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
India-discovered levonadifloxacin & alalevonadifloxacin: A review on susceptibility testing methods, CLSI quality control and breakpoints along with a brief account of their emerging therapeutic profile as a novel standard-of-care.
Veeraraghavan B, Bakthavatchalam YD, Manesh A, Lal B, Swaminathan S, Ansari A, Subbareddy K, Rangappa P, Choudhuri AH, Nagvekar V, Mehta Y, Appalaraju B, Baveja S, Baliga S, Shenoy S, Bhardwaj R, Kongre V, Dattatraya GS, Verma B, Mukherjee DN, Gupta S, Shanmugam P, Iravane J, Mishra SR, Barman P, Chopra S, Hariharan M, Surpam R, Pratap R, Turbadkar D, Taklikar S; Drug Discovery group, Wockhardt. Veeraraghavan B, et al. Among authors: mukherjee dn. Indian J Med Microbiol. 2023 Jan-Feb;41:71-80. doi: 10.1016/j.ijmmb.2022.11.005. Epub 2022 Dec 9. Indian J Med Microbiol. 2023. PMID: 36509611 Review.
Treatment challenges in the management of difficult-to-treat gram-positive infections: A consensus view apropos therapeutic role of novel anti-MRSA antibiotics, levonadifloxacin (IV) and alalevonadifloxacin (oral).
Saseedharan S, Dubey D, Singh RK, Zirpe K, Choudhuri AH, Mukherjee DN, Gupta N, Sahasrabudhe S, Soni S, Kulkarni S, Walse P, Vora AC, Thomas J, Tayade A, Bhadarke G, Kishore K, Paliwal Y, Patil P, Reddy PK, Nagvekar V, Veeraraghavan B. Saseedharan S, et al. Among authors: mukherjee dn. Indian J Med Microbiol. 2024 Jan-Feb;47:100528. doi: 10.1016/j.ijmmb.2024.100528. Epub 2024 Jan 21. Indian J Med Microbiol. 2024. PMID: 38228227
In vitro activity of Ceftazidime-Avibactam and its comparators against Carbapenem resistant Enterobacterales collected across India: results from ATLAS surveillance 2018 to 2019.
Bakthavatchalam YD, Routray A, Mane A, Kamat S, Gupta A, Bari AK, Rohit A, Poojary A, Mukherjee DN, Sethuraman N, Munshi N, Shah S, Balaji V, Gupta Y. Bakthavatchalam YD, et al. Among authors: mukherjee dn. Diagn Microbiol Infect Dis. 2022 May;103(1):115652. doi: 10.1016/j.diagmicrobio.2022.115652. Epub 2022 Jan 31. Diagn Microbiol Infect Dis. 2022. PMID: 35255290 Free article.
Distinctive Mobile Genetic Elements Observed in the Clonal Expansion of Carbapenem-Resistant Klebsiella pneumoniae in India.
Shankar C, Jacob JJ, Sugumar SG, Natarajan L, Rodrigues C, Mathur P, Mukherjee DN, Sharma A, Chitnis DS, Bharagava A, Manesh A, Gunasekaran K, Veeraraghavan B. Shankar C, et al. Among authors: mukherjee dn. Microb Drug Resist. 2021 Aug;27(8):1096-1104. doi: 10.1089/mdr.2020.0316. Epub 2021 Mar 15. Microb Drug Resist. 2021. PMID: 33720791
18 results